Kyowa Kirin Co. (OTCMKTS:KYKOF) fell 1.5% during trading on Friday . The company traded as low as $21.00 and last traded at $21.00, 150 shares changed hands during mid-day trading. A decline of 98% from the average session volume of 7,493 shares. The stock had previously closed at $21.33.

Separately, Jefferies Financial Group began coverage on Kyowa Kirin in a research report on Monday, December 9th. They issued a “buy” rating on the stock.

The company’s 50-day moving average price is $21.65.

About Kyowa Kirin (OTCMKTS:KYKOF)

Kyowa Kirin Co, Ltd., specialty pharmaceutical company, manufactures and markets pharmaceuticals focused on the therapeutic areas of oncology, nephrology, central nervous system, and immunology worldwide. Its products include ABSTRAL, a sublingual formulation of fentanyl used for the management of episodes of breakthrough pain experienced by cancer patients; ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; GRAN, a human colony-stimulating factor; and G-LASTA/Peglasta/Neulasta for chemotherapy-induced febrile neutropenia.

Featured Article: Portfolio Manager

Receive News & Ratings for Kyowa Kirin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kyowa Kirin and related companies with MarketBeat.com's FREE daily email newsletter.